Literature DB >> 30203452

Anticoagulation in the cardiac patient: A concise review.

Elise A Larson1, David M German2, Joseph Shatzel1, Thomas G DeLoughery1.   

Abstract

Anticoagulation has multiple roles in the treatment of cardiovascular disease, including in management of acute myocardial infarction, during percutaneous coronary intervention, as stroke prophylaxis in patients with atrial arrhythmias, and in patients with mechanical heart valves. Clinical anticoagulation choices in the aforementioned diseases vary widely, due to conflicting data to support established agents and the rapid evolution of evidence-based practice that parallels more widespread use of novel oral anticoagulants. This review concisely summarizes evidence-based guidelines for anticoagulant use in cardiovascular disease, and highlights new data specific to direct oral anticoagulants.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  anticoagulation; atrial fibrillation; cardiovascular disease; direct oral anticoagulants; novel oral anticoagulants; nste-acs

Mesh:

Substances:

Year:  2018        PMID: 30203452     DOI: 10.1111/ejh.13171

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  Can we reduce bleeding risk after interventional procedures?

Authors:  Farrel Hellig
Journal:  Cardiovasc J Afr       Date:  2021 Jan-Feb       Impact factor: 1.167

2.  Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting Assay: A Prospective, Single-Arm, Open-Label Study.

Authors:  Alan Yean Yip Fong; Lee Len Tiong; Shirley Siang Ning Tan; Dominic Geruka; Gerald Grino Apil; Chee Wei Choo; Tiong Kiam Ong
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.